RNA-transfection of gamma/delta T cells with a chimeric antigen receptor or an alpha/ss T-cell receptor: a safer alternative to genetically engineered alpha/ss T cells for the immunotherapy of melanoma

Harrer D, Simon B, Fujii SI, Kanako S, Uslu U, Schuler G, Gerer KF, Hoyer S, Dörrie J, Schaft N (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

European Journal of Immunology Wiley-VCH Verlag

Book Volume: 47

Pages Range: 10-10

Authors with CRIS profile

Ugur Uslu Department of Dermatology Gerold Schuler Lehrstuhl für Haut- und Geschlechtskrankheiten Jan Dörrie Department of Dermatology Niels Schaft Department of Dermatology

Involved external institutions

IMS RIKEN Center for Integrative Medical Sciences JP Japan (JP)

How to cite

APA:

Harrer, D., Simon, B., Fujii, S.I., Kanako, S., Uslu, U., Schuler, G.,... Schaft, N. (2017). RNA-transfection of gamma/delta T cells with a chimeric antigen receptor or an alpha/ss T-cell receptor: a safer alternative to genetically engineered alpha/ss T cells for the immunotherapy of melanoma. (pp. 10-10).

MLA:

Harrer, D., et al. "RNA-transfection of gamma/delta T cells with a chimeric antigen receptor or an alpha/ss T-cell receptor: a safer alternative to genetically engineered alpha/ss T cells for the immunotherapy of melanoma." 2017. 10-10.

BibTeX: Download